Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Udo Bongartz"'
Autor:
Udo Bongartz, Uwe Hochmann, Barbara Grube, Ralf Uebelhack, Felix Alt, Constantin Erlenbeck, Li Vern Peng, Pee Win Chong, Patricia De Costa
Publikováno v:
Obesity Facts (2022)
Introduction: The aim of this study was to evaluate the benefit and tolerability of two dosages of a proprietary flaxseed mucilage (IQP-LU-104) in reducing body weight in overweight and moderately obese individuals. Methods: In a double-blind, random
Externí odkaz:
https://doaj.org/article/8d3a1bf13a48405bb8c1d74886d6d4ff
Autor:
Ralf Uebelhack, Udo Bongartz, Stephanie Seibt, Gordana Bothe, Pee Win Chong, Patricia De Costa, Natalia Wszelaki
Publikováno v:
Journal of Obesity, Vol 2019 (2019)
Objective. This study was performed to determine the efficacy and tolerability/safety of IQP-AE-103 on body weight reduction in overweight to moderately obese adults. Methods. A double-blind, randomized, placebo-controlled trial involved one hundred
Externí odkaz:
https://doaj.org/article/6fb5c1401b1b4352837cbbcf4e6f75c9
Autor:
Ralf Uebelhack, Udo Bongartz, Stephanie Seibt, Gordana Bothe, Pee Win Chong, Patricia De Costa, Natalia Wszelaki
Publikováno v:
Journal of Obesity, Vol 2019 (2019)
Externí odkaz:
https://doaj.org/article/c38738680a0f46128f99c848aca48fa8
Publikováno v:
Food and Nutrition Sciences. 13:424-438
Autor:
Gordana Bothe, Natalia Wszelaki, Ralf Uebelhack, Patricia De Costa, Stephanie Seibt, Pee Win Chong, Udo Bongartz
Publikováno v:
Journal of Obesity, Vol 2019 (2019)
Journal of Obesity
Journal of Obesity
Objective. This study was performed to determine the efficacy and tolerability/safety of IQP-AE-103 on body weight reduction in overweight to moderately obese adults.Methods. A double-blind, randomized, placebo-controlled trial involved one hundred a
Autor:
Uwe Hochmann, Gordana Bothe, Lynette Chew, Pee-Win Chong, Udo Bongartz, Ute Pohl, Patricia De Costa, Ralf Uebelhack
Publikováno v:
Experimental and Therapeutic Medicine
Intense and prolonged exercise leads to immune suppression, causing upper respiratory tract infections (URTI). A proprietary standardized dietary supplement, IQP-AS-119 has been previously developed to aid immune responses under such conditions. The
Publikováno v:
PharmaNutrition. 6:113-118
IQP-VV-102, containing L-arabinose and grape marc extract has been shown to promote weight loss. The present study investigated the efficacy of IQP-VV-102 on postprandial blood glucose reduction. Seventeen healthy overweight Caucasians were randomly
Publikováno v:
Advancement in Medicinal Plant Research. 6:13-18
Publikováno v:
Experimental and Therapeutic Medicine
Cardiovascular diseases are the main cause of death in the industrialized world, with the main risk factors being elevated blood pressure and blood lipid levels, leading to arterial stiffness and arteriosclerosis. In this study, we examined the effec
Autor:
Natalia Wszelaki, Pee-Win Chong, Udo Bongartz, Ralf Uebelhack, Stephanie Seibt, Bee-Kwan Tan, Gordana Bothe
Publikováno v:
Evidence-Based Complementary and Alternative Medicine, Vol 2019 (2019)
Evidence-based Complementary and Alternative Medicine : eCAM
Evidence-based Complementary and Alternative Medicine : eCAM
Objective. The purpose of this study was to explore the clinical benefit and tolerability of IQP-AO-101 in healthy subjects with sleep complaints. Methods. This double-blind, randomized, placebo-controlled trial involved fifty subjects with sleep com